What is OS Therapies's invested purchaser?

OS Therapies (OSTX) reported invested purchaser of $25K in Q4 2025.

What does invested purchaser mean?

Identifies the total capital contributed by specific strategic or institutional investors during a financing round. This metric tracks the level of commitment from key stakeholders and their ongoing financial support for the company's clinical or commercial development.

OS Therapies OSTX Invested Purchaser

Invested Purchaser at other companies

Blue Owl CapitalOWL

$176.11M-8.2%

FRA

Franklin Financial Services CorporationFRAF

-$78K+18.3%

StepStone Group Inc.STEP

$1.33M-35.1%

Federated HermesFHI

$1.4M-20.2%

Fox CorporationFOXA

$25M—

BGC Group, Inc.BGC

$48.38M—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:InvestedPurchaser.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's invested purchaser.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's invested purchaser?: OS Therapies (OSTX) reported invested purchaser of $25K in Q4 2025.
What does invested purchaser mean?: Identifies the total capital contributed by specific strategic or institutional investors during a financing round. This metric tracks the level of commitment from key stakeholders and their ongoing financial support for the company's clinical or commercial development.